Cellular Classification
The pathologist has a central role in the evaluation of carcinoma of unknown
primary (CUP). A thorough evaluation of an adequate specimen for
histologic, immunohistochemical, and, when appropriate, electron microscopic
evaluations is probably the most important clue in the diagnostic
puzzle of CUP. Pathologic evaluations provide guidance for an appropriate clinical
evaluation. An obvious corollary to the pathologist’s role is the critical
interaction between the pathologist, oncologist, and primary physician.[1]
The complexity of the pathologic evaluation tends to be inversely related to
the degree of differentiation of the tumor. For well- or moderately differentiated tumors, the pathologic diagnosis of an epithelial cancer versus
lymphoma, sarcoma, melanoma, or a germ cell tumor, for instance, is often
readily apparent. Commonly used histologic stains such as mucicarmine or
diastase-sensitive Periodic Acid Schiff can be important in confirming the
diagnosis of certain tumors of gastrointestinal or renal origin.
Special studies can help in distinguishing tumors that are poorly differentiated;[2,3] the generic distinction between a poorly differentiated
tumor of epithelial, hematopoietic, or neuroectodermal origin (i.e., melanoma)
is important. Microsatellite analysis has been used to assess genetic
alterations in cervical lymph nodes. These alterations were identical in 18 patients with normal mucosal histology and malignant nodes,
suggesting a site of primary tumor origin.[4]
Other diagnostic tests:
-
Immunohistochemical analysis: Several studies can be important in making these broad distinctions; in
particular, studies that evaluate staining for keratins, leukocyte common
antigen, and S-100, a neuroectodermal antigen expressed in melanomas.[5]
-
Prostate-specific antigen (PSA) analysis: This histochemical study can accurately differentiate tumors of prostatic
origin from other types of cancer. Prostate cancer is most often found by digital rectal examination. Approximately
3% of CUPs are ultimately shown to be prostate cancer. These cancers, as
mentioned above, appear to have a different metastatic distribution than the
predominant bony distribution that is generally encountered in prostate cancer.
When the primary disease may be suspected to have arisen from
the prostate, prostate cancer-specific tests should be performed to rule out a diagnosis of primary prostate cancer.[6]
-
Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) analysis:
Immunohistochemical stains are available for both of these proteins. Although
neither protein is absolutely specific for germ cell tumors, and AFP is not specific for hepatoma, they are important because germ cell tumors are effectively treated with
combination chemotherapy; appropriate therapy may lead to cure.[7] The finding of germ cell tumors by genetic
analysis has been associated with a high response rate to cisplatin therapy,
thus suggesting that molecular or cytogenetic studies may be useful in
identifying undifferentiated tumors that are otherwise unclassifiable.[8]
-
Polymerase chain reaction analysis: In patients with suspected nasopharyngeal carcinoma, DNA amplification of
Epstein-Barr virus (EBV) genomes can be used for diagnosis with tissue provided
by fine-needle aspiration biopsy. The presence of EBV in metastases from an
occult primary tumor suggests the development of overt nasopharyngeal
carcinoma.[9] A single study has shown that the i(12p) marker chromosome may
be used as a diagnostic tool in patients with suspected midline germ cell
tumors.[10]
-
Electron microscopic analysis: Electron microscopy (EM) evaluation can sometimes aid in the diagnosis of CUP.
In particular, the presence of desmosomes and bundles of tonofilaments are
characteristic of squamous cell cancers. The presence of core granules that
are diagnostic of neuroendocrine origin is seen in poorly differentiated
neuroendocrine tumors of unknown primary site.[11]
Acinar spaces and microacinic spaces are seen with adenocarcinomas. Electron
dense secretory granules are seen in tumors of neuroectodermal origin.
Premelanosomes can be found in most amelanotic melanomas.
The features mentioned above are generally associated with differentiation
along a particular line. Often poorly differentiated tumors do not display
such characteristics, making the EM evaluation of little value. It is
estimated that EM may aid in distinguishing a primary diagnosis that has not
been obtained by light microscopy approximately 10% of the time.[12-14]
Because of the development of immunohistochemical stains, EM is rarely needed.
References
-
Haskell CM, Cochran AJ, Barsky SH, et al.: Metastasis of unknown origin. Curr Probl Cancer 12 (1): 5-58, 1988 Jan-Feb.
[PUBMED Abstract]
-
Ruddon RW, Norton SE: Use of biological markers in the diagnosis of cancers of unknown primary tumor. Semin Oncol 20 (3): 251-60, 1993.
[PUBMED Abstract]
-
Mackay B, Ordonez NG: Pathological evaluation of neoplasms with unknown primary tumor site. Semin Oncol 20 (3): 206-28, 1993.
[PUBMED Abstract]
-
Califano J, Westra WH, Koch W, et al.: Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst 91 (7): 599-604, 1999.
[PUBMED Abstract]
-
Battifora H: Recent progress in the immunohistochemistry of solid tumors. Semin Diagn Pathol 1 (4): 251-71, 1984.
[PUBMED Abstract]
-
Yam LT, Winkler CF, Janckila AJ, et al.: Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase. Cancer 51 (2): 283-7, 1983.
[PUBMED Abstract]
-
Greco FA, Hainsworth JD: Cancer of unknown primary site. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds.: Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2005, 2213-34.
-
Motzer RJ, Rodriguez E, Reuter VE, et al.: Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 13 (1): 274-82, 1995.
[PUBMED Abstract]
-
Feinmesser R, Miyazaki I, Cheung R, et al.: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 326 (1): 17-21, 1992.
[PUBMED Abstract]
-
Bosl GJ, Ilson DH, Rodriguez E, et al.: Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J Natl Cancer Inst 86 (5): 349-55, 1994.
[PUBMED Abstract]
-
Hainsworth JD, Johnson DH, Greco FA: Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 109 (5): 364-71, 1988.
[PUBMED Abstract]
-
Hanna W, Kahn HJ: The ultrastructure of metastatic adenocarcinoma in serous fluids. An aid in identification of the primary site of the neoplasm. Acta Cytol 29 (3): 202-10, 1985 May-Jun.
[PUBMED Abstract]
-
Herrera GA, Reimann BE: Electron microscopy in determining origin of metastatic adenocarcinomas. South Med J 77 (12): 1557-66, 1984.
[PUBMED Abstract]
-
Mackay B, Ordonez NG: The role of the pathologist in the evaluation of poorly differentiated tumors. Semin Oncol 9 (4): 396-415, 1982.
[PUBMED Abstract]
Back to Top
< Previous Section | Next Section > |